pubmed-article:20817564 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20817564 | lifeskim:mentions | umls-concept:C1709854 | lld:lifeskim |
pubmed-article:20817564 | lifeskim:mentions | umls-concept:C0011109 | lld:lifeskim |
pubmed-article:20817564 | lifeskim:mentions | umls-concept:C0079220 | lld:lifeskim |
pubmed-article:20817564 | lifeskim:mentions | umls-concept:C0181598 | lld:lifeskim |
pubmed-article:20817564 | lifeskim:mentions | umls-concept:C1708476 | lld:lifeskim |
pubmed-article:20817564 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:20817564 | pubmed:dateCreated | 2010-11-24 | lld:pubmed |
pubmed-article:20817564 | pubmed:abstractText | The use of left ventricular assist devices (LVADs) as destination therapy (DT) is increasing and has proven beneficial in prolonging survival and improving quality of life in select patients with end-stage heart failure. Nonetheless, end-of-life (EOL) issues are inevitable and how to approach them underreported. | lld:pubmed |
pubmed-article:20817564 | pubmed:language | eng | lld:pubmed |
pubmed-article:20817564 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20817564 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20817564 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20817564 | pubmed:month | Dec | lld:pubmed |
pubmed-article:20817564 | pubmed:issn | 1557-3117 | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:DotyJohn RJR | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:AlharethiRami... | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:BrushSallyS | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:DrakosStavros... | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:KfouryAbdalla... | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:ReidBruce BBB | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:ClaysonStephe... | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:SmithHildegar... | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:StokerSandiS | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:BudgeDeborahD | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:McCormickAshl... | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:MacPhersonJan... | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:LedfordIan... | lld:pubmed |
pubmed-article:20817564 | pubmed:author | pubmed-author:CaineWilliam... | lld:pubmed |
pubmed-article:20817564 | pubmed:copyrightInfo | Copyright © 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved. | lld:pubmed |
pubmed-article:20817564 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20817564 | pubmed:volume | 29 | lld:pubmed |
pubmed-article:20817564 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20817564 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20817564 | pubmed:pagination | 1337-41 | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:meshHeading | pubmed-meshheading:20817564... | lld:pubmed |
pubmed-article:20817564 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20817564 | pubmed:articleTitle | End-of-life decision making and implementation in recipients of a destination left ventricular assist device. | lld:pubmed |
pubmed-article:20817564 | pubmed:affiliation | Utah Artificial Heart Program, and Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, Utah 84107, USA. | lld:pubmed |
pubmed-article:20817564 | pubmed:publicationType | Journal Article | lld:pubmed |